Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Alessi

Showing results (91-100 of 147) with videos related to

Pageof 15
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Platelet function after a high dose bolus of tirofiban immediately after coronary angioplasty]F Barbou, C Frère, T Hovasse, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.
Thrombosis and Haemostasis|December 8, 1998
A three-generation family presenting five cases of homozygosity for the 20210 G to A prothrombin variantP E Morange, M C Barthet, M Henry, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2005
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndromeT Cuisset, C Frere, J Quilici, et al.
Thrombosis and Haemostasis|July 4, 2001
Adipose tissue expression of gelatinases in mouse models of obesityH R Lijnen, E Maquoi, P Holvoet, et al.
Thrombosis and Haemostasis|January 4, 1998
Acquired protein S deficiency, likely due to anti-PS autoantibodies, following a thrombotic event in a patient with a systemic lupus erythematosusP E Morange, M C Alessi, M C Barthet, et al.
Diabetologia|November 24, 2001
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight lossA Mavri, M C Alessi, D Bastelica, et al.
Thrombosis and Haemostasis|January 23, 1992
Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levelsI Juhan-Vague, M C Alessi, D Raccah, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2011
CD11b+ leukocyte microparticles are associated with high-risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromesD Faille, C Frere, T Cuisset, et al.
Clinical Genetics|July 15, 2016
Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM studyP Suchon, F Al Frouh, M Ibrahim, et al.
Pageof 15

Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 15, 2006
[Platelet function after a high dose bolus of tirofiban immediately after coronary angioplasty]F Barbou, C Frère, T Hovasse, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.
Thrombosis and Haemostasis|December 8, 1998
A three-generation family presenting five cases of homozygosity for the 20210 G to A prothrombin variantP E Morange, M C Barthet, M Henry, et al.
Journal of Thrombosis and Haemostasis : JTH|December 24, 2005
High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndromeT Cuisset, C Frere, J Quilici, et al.
Thrombosis and Haemostasis|July 4, 2001
Adipose tissue expression of gelatinases in mouse models of obesityH R Lijnen, E Maquoi, P Holvoet, et al.
Thrombosis and Haemostasis|January 4, 1998
Acquired protein S deficiency, likely due to anti-PS autoantibodies, following a thrombotic event in a patient with a systemic lupus erythematosusP E Morange, M C Alessi, M C Barthet, et al.
Diabetologia|November 24, 2001
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight lossA Mavri, M C Alessi, D Bastelica, et al.
Thrombosis and Haemostasis|January 23, 1992
Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levelsI Juhan-Vague, M C Alessi, D Raccah, et al.
Journal of Thrombosis and Haemostasis : JTH|June 29, 2011
CD11b+ leukocyte microparticles are associated with high-risk angiographic lesions and recurrent cardiovascular events in acute coronary syndromesD Faille, C Frere, T Cuisset, et al.
Clinical Genetics|July 15, 2016
Genetic risk factors for venous thrombosis in women using combined oral contraceptives: update of the PILGRIM studyP Suchon, F Al Frouh, M Ibrahim, et al.
Pageof 15